Comparative effectiveness review of antiplatelet agents in peripheral artery disease

J Am Heart Assoc. 2014 Dec 4;3(6):e001330. doi: 10.1161/JAHA.113.001330.

¹ Department of Community and Family Medicine, Duke University School of Medicine, Durham, NC (K.S.) Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (K.S., R.J.D., S.J., M.R.P.).
² Division of General Internal Medicine, Duke University Medical Center, Durham, NC (R.J.D.) Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (K.S., R.J.D., S.J., M.R.P.) Duke Evidence-based Practice Center, Duke Clinical Research Institute, Duke University, Durham, NC (R.J.D., B.H.).
³ Division of Cardiology, Duke University Medical Center, Durham, NC (S.J., S.V., S.S., M.R.P.) Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (K.S., R.J.D., S.J., M.R.P.).
⁴ Division of Cardiology, Duke University Medical Center, Durham, NC (S.J., S.V., S.S., M.R.P.).
⁵ Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC (V.H.).
⁶ Duke Evidence-based Practice Center, Duke Clinical Research Institute, Duke University, Durham, NC (R.J.D., B.H.).

No abstract available

Keywords: antiplatelet therapy; aspirin; clopidogrel; peripheral artery disease.

Publication types